Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease - Wikidata - awgldk - TriplyDB

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

http://www.wikidata.org/entity/Q37390635

about

Atherosclerosis and infection: is the jury still not in?Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions The clinics of acute coronary syndrome What happens to cardiovascular system behind the undetectable level of HIV viremia?Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus Metabolic syndrome, diabetes, and cardiovascular risk in HIV The role of oxidative stress and inflammation in cardiovascular aging Menopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implications Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy HIV infection and cardiovascular disease Diagnosing and managing diabetes in HIV-infected patients: current concepts HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities HIV and aging: emerging research issues Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?The role of statins in the setting of HIV infection Identifying the appropriate comparison group for HIV-infected individuals HIV infection and the risk of acute myocardial infarction.Untangling the Gordian knot of HIV, stress, and cognitive impairment Role of high-sensitivity C-reactive protein measurements in HIV patients A Review of Management of Inflammation in the HIV Population Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat Managing dyslipidemia in HIV/AIDS patients: challenges and solutions Cardiovascular Complications of HIV-Associated Immune Dysfunction A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine Cohort Factors associated with tobacco smoking and cessation among HIV-infected individuals under care in Rio de Janeiro, Brazil A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study Ageing and inflammation in patients with HIV infection.Cardiovascular Complications of HIV in Endemic Countries.Cardiovascular Disease, Statins, and HIV Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography.

P2860

Q22241306-69E6C8BD-5190-4687-8C64-28447973124B Q26740117-179E9FCC-7AE8-43DE-8173-CCE311AC9AD6 Q26746739-48641D49-8C08-47CB-9308-FE700E1FE6D7 Q26749024-C7012714-1D4C-4680-B726-81BFB706D1E9 Q26777866-B4672EE3-496B-4755-8216-FB092BA569C3 Q26851535-4C245D48-0737-4604-9ED0-1FF8347565AD Q26853470-7BB08FD3-825C-46B7-B673-A213C49E3162 Q26864987-611C3C26-1C42-4813-87E5-4C2074BEA9B3 Q26865187-22C19999-72F5-4A61-BC13-E4C750C9879F Q27000959-8581DE00-66A4-4F33-ADA1-A0F9822B7759 Q27008328-85C2A485-BD16-42B2-94F8-2E5A0F6688EA Q27008915-73E6E707-6FAB-4291-9261-DF63D52F6925 Q27014697-BE1EC39C-B8F3-4702-A822-31AAEB36FE74 Q27015965-F9DF00D8-7A17-4B14-A41C-FEB00DE3C4E7 Q27016011-6E53FD39-1E54-4321-9840-F397C30A64CC Q27024262-AD8E588D-5535-4760-9892-7E380491DF86 Q27026486-D17F668E-050F-429F-9DDD-A29A947DA5DA Q27027724-573EF6BD-9E4B-43C8-84B8-C2317A4AD364 Q27028033-93E6EA27-91FD-44B1-8C0D-14BEB185E531 Q27347231-FBAA7AF8-FF13-48B5-9C11-744EF1F98794 Q28067483-7CEC3A65-ED8B-4208-89A7-D411B75D0DDE Q28067891-AF33BE4A-7297-4915-8FA8-B629D0D67E91 Q28078962-B88EB198-B574-4886-8B2D-4F118A97A682 Q28079826-6B15BDB8-1D34-43C6-BFDB-4DDC6DAF472A Q28080948-E589B72D-5F91-4FC8-9391-FB31EEF3FEAC Q28084941-AFDDF09E-467B-4B9D-8285-3E62724F7724 Q28084981-F7FC723C-8CCF-46C8-9F75-3F848572E351 Q28385694-8953BD8C-3794-434B-846E-E0724EB0EFA7 Q28386344-A83EB998-6FB9-43D0-BADD-75FE3ACE9A22 Q28541356-6081320B-67A7-4546-8E5F-D01075453367 Q28542839-5839E5EA-A304-4C50-9A93-DBAA8793FF9E Q28543212-CC8F51F1-8E92-4EA3-9542-BA042CE626EA Q28743987-2D3A532D-DCFC-41F6-B134-8A67B39E5C48 Q28744647-820F289F-24FC-4AC7-88F0-F48EBF1E028A Q30244296-73158821-1448-40DD-8E50-4BED79FDEA85 Q30244655-877617D4-F403-446C-A443-68E37400CBC9 Q30245373-C05F130A-A9F8-45F4-8BB9-E24E549E0908 Q30248286-5E4C288D-3E72-4175-A1C7-C83A60C7A446 Q30366554-40432014-FD88-4089-8D1C-84EEA30AFAFF Q30457521-D8A71A7A-2886-42FA-A04E-E0E7A675C0F0

P2860

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

http://www.wikidata.org/entity/Q37390635

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 April 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased acute myocardial inf ...... immunodeficiency virus disease

@en

Increased acute myocardial inf ...... mmunodeficiency virus disease.

@nl

type

label

Increased acute myocardial inf ...... immunodeficiency virus disease

@en

Increased acute myocardial inf ...... mmunodeficiency virus disease.

@nl

prefLabel

Increased acute myocardial inf ...... immunodeficiency virus disease

@en

Increased acute myocardial inf ...... mmunodeficiency virus disease.

@nl

P1433

Q37390635-7905502D-A170-465E-AA92-0050ABC0AEA7

P1476

Q37390635-AF1C6F53-D762-45B2-88F0-A3148BD2191C

P2093

Q37390635-0EA1C92C-69D8-4718-A567-11F6F1E8FDD5

Q37390635-63394818-9FFC-4C3F-ABDA-97FC9BB1AB49

Q37390635-E008F9E7-29F3-4673-96BA-C418AE3A0554

Q37390635-FB3D63B9-C0A6-449F-9DAA-628FCBC5D64B

P2860

Q37390635-1730FECA-FA3D-4AFF-872F-F9D12EAC0496

Q37390635-1D73C314-C63A-4E96-BACB-FA141E328D63

Q37390635-25265714-9372-425B-BB07-45E840E9E48D

Q37390635-3182B464-613A-420B-A731-604EC1383600

Q37390635-3263159C-4D2E-4350-A2D0-40DD60F6083D

Q37390635-37473072-6391-48C5-AECF-B50ECF2BDC84

Q37390635-5543FE78-7988-4148-9891-B56FDD026B1C

Q37390635-5AB4C97E-D519-431F-9B42-9CA8CF8471AD

Q37390635-633E0EB3-9E79-4652-8160-18842AC0EC6C

Q37390635-6A9DDCB2-2CDC-4CF4-ADA3-5D4204EA5C1B

P304

Q37390635-63D260B2-B3EB-4AD4-A196-99D3457C8495

P31

Q37390635-58C03BA3-490A-4526-B89B-3FC8F75CC6C0

P356

Q37390635-4E0E30BF-64A9-407D-9D8B-298239198CA3

P407

Q37390635-7407F44A-A99D-4C17-8EFB-F73D75C44D4F

P433

Q37390635-97808A41-ADEB-4B58-AA3C-F4FD36BDC118

P478

Q37390635-FAA8738C-4774-4985-9967-1345B0179318

P577

Q37390635-A9EC3819-44F3-4F7A-9E12-D0D7CF17D52C

P5875

Q37390635-1F27463C-22C0-47E5-8DF6-8BBB736667D5

P698

Q37390635-96476445-FC75-417D-B4AE-279FB56176A4

P921

Q37390635-34CC8F93-7108-487C-8A84-7C47ABEE9D03

Q37390635-87E318DB-F5B4-45AC-B762-1C664AD65676

Q37390635-A815C834-99C4-4D0F-AECF-259388960248

P932

Q37390635-F0BDB8D9-C4BD-4C15-BB1A-609ECE03C3A1

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Increased acute myocardial inf ...... immunodeficiency virus disease

@en

P2093

Colleen Hadigan

http://www.w3.org/2001/XMLSchema#string

Hang Lee

http://www.w3.org/2001/XMLSchema#string

Steven K Grinspoon

http://www.w3.org/2001/XMLSchema#string

Virginia A Triant

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Indinavir impairs endothelial function in healthy HIV-negative men

Inflammation, atherosclerosis, and coronary artery disease

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative.

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols.

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.

P304

2506-2512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2006-2190

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6371747

http://www.w3.org/2001/XMLSchema#string

P698

17456578

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2763385

http://www.w3.org/2001/XMLSchema#string